In a xenograft model of human B‐cell non‐Hodgkin lymphoma (B‐NHL), NOG mice treated with cryopreserved CD19‐CAR‐DNTs exhibited robust tumor growth inhibition (TGI). This evidence concerns the gene CD19 and neoplasm.